Evidence map›Paper›PMID 42337451›Full record

ArticleBMC pediatrics2026

Recurrent and unusual infections unmasking a rare inborn error of immunity: a case report RAS-associated Autoimmune Lymphoproliferative Disease (RALD).

Mohamad Qazreen Ahmad Shawaludin, Mohd Anas Che Nik, Zarina Thasneem Zainudeen, Fahisham Taib, Intan Juliana Abd Hamid

Abstract readCase Reports
In one paragraph

Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohamad Qazreen Ahmad ShawaludinDepartment of Pediatrics, School of Medical Sciences, Universiti Sains Malaysia, Jalan Perempuan Zainab II, Kubang Kerian, Kota Bahru, Kelantan, 16150, Malaysia.
Mohd Anas Che NikDepartment of Pediatrics, School of Medical Sciences, Universiti Sains Malaysia, Jalan Perempuan Zainab II, Kubang Kerian, Kota Bahru, Kelantan, 16150, Malaysia.
Zarina Thasneem ZainudeenDepartment of Clinical Medicine, Primary Immunodeficiency Disease Group, Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, Kepala Batas, Pulau Pinang, 13200, Malaysia.
Fahisham TaibDepartment of Pediatrics, School of Medical Sciences, Universiti Sains Malaysia, Jalan Perempuan Zainab II, Kubang Kerian, Kota Bahru, Kelantan, 16150, Malaysia.
Intan Juliana Abd HamidHospital Pakar Universiti Sains Malaysia, Universiti Sains Malaysia, Kubang Kerian, Kota Bahru, Kelantan, 16150, Malaysia. intanj@usm.my.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRAS-associated Autoimmune Lymphoproliferative Disease (RALD) is a rare, non-malignant lymphoproliferative disorder caused by somatic mutations in RAS genes that impair lymphocyte apoptosis. Patients often present with features of lymphoproliferation, autoimmune manifestations, and an increased risk of malignant transformation. CASE PRESENTATION: We report the case of a 3-year-old boy with splenic microabscesses and Burkholderia pseudomallei IgM serology positivity, who was treated as melioidosis. He had recurrent respiratory infections and chronic rhinorrhoea since the age of one year. Clinical examination revealed persistent lymphadenopathy and hepatosplenomegaly. Laboratory investigations demonstrated persistent absolute monocytosis and thrombocytopenia, while immunological evaluation showed elevated IgM levels and B-cell lymphocytosis. Whole exome sequencing identified a heterozygous pathogenic variant in NRAS, NM_002524.5:c.35G > C, NP_002515.1:p.Gly12Ala, establishing the diagnosis of RALD. The patient was subsequently started on antibiotic prophylaxis and immunoglobulin replacement therapy, and his family was counseled regarding the potential role of immunosuppressive therapy and hematopoietic stem cell transplantation (HSCT) in future management.

conclusionsThis case highlights the coexistence of an unusual infection with a rare inborn error of immunity, expanding the recognized infectious spectrum of RALD. It underscores the importance of considering RALD in patients presenting with recurrent or atypical infections and persistent lymphoproliferative features. Early recognition and molecular genetic testing are essential for confirming the diagnosis and guiding individualized management.

Indexed as

Autoimmune Lymphoproliferative SyndromeGenes, rasChild, PreschoolHumansLymphadenopathyMaleRecurrenceRespiratory Tract InfectionsSplenomegalyAutoimmune Lymphoproliferative Syndrome (ALPS)NRASRALDRAS-associated Autoimmune Lymphoproliferative DiseaseRAS gene

Identifiers

PMID42337451
PMCPMC13551796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.